These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 16235155)

  • 1. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial.
    Leung KY; Ling M; Tang GW
    Maturitas; 2005; 52(3-4):277-85. PubMed ID: 15950409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ; Zuckerman IH; Lee E
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of hormone replacement therapy on metabolic syndrome components in perimenopausal women.
    Korljan B; Bagatin J; Kokić S; Berović Matulić N; Barsić Ostojić S; Deković A
    Med Hypotheses; 2010 Jan; 74(1):162-3. PubMed ID: 19665311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
    Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and cardiovascular disease revisited.
    Stevenson JC
    Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.